06/05/2025 13:00
Capcom’s New Sci-Fi Action-Adventure Game PRAGMATA to Launch in 2026!

Capcom Co., Ltd. (TOKYO:9697) today announced that PRAGMATA, a highly anticipated all-new IP, is scheduled for release in 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605459835/en/ PRAGMATA Key Art PRAGMATA is a sci-fi action-adventure game that takes place on the moon in a near-future world. In the game, two compel...

06/10/2025 12:31
Fortis Healthcare Recognized for its Global Contribution to Medical Value Travel at Advantage Healthcare India 2025

Advantage Healthcare India 2025, an International Summit dedicated to advancing India's position as a global hub for medical value travel has recognized Fortis Healthcare’s global contribution to medical value travel, where Fortis has contributed to India's reputation as a leading destination for medical tourism. Fortis Healthcare bagged Advantage Healthcare India's Medical Value Travel Awards 2025 in 7 categories. Fortis Escorts Heart Institute, Okhla was recognized for its contribution t...

06/10/2025 12:30
Hypernative Raises $40M Series B to Remove Security Barriers to Web3 Mass Adoption

Hypernative, the leading provider of real-time threat prevention in Web3, today announced a $40 million Series B funding round co-led by Ten Eleven Ventures and Ballistic Ventures, with participation from StepStone Group, and existing investors boldstart ventures and IBI Tech Fund. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250610162307/en/Hypernative team The funds will support the expansion of the company’s offering to include...

05/07/2025 09:00
AACR 2025: Brenus Pharma Presents Late-breaking Preclinical Data on its “off-the-shelf” Next-generation Vaccine-based Immunotherapy Candidate, STC-1010, Now Moving to Clinic

Brenus Pharma, a French clinical-stage biotechnology company, presented new preclinical data on its lead immunotherapy candidate, STC-1010, during the Late-Breaking Research: Immunology 3 session at the AACR Annual Meeting 2025, held April 25–30 in Chicago, IL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250507231535/en/George Alzeeb, PhD, Innovation Manager at Brenus Pharma, presenting the company’s latest preclinical data on STC...

06/13/2025 04:05
Vietnam’s FPT Corporation and Indonesia’s Bappenas Forge Strategic Partnership to Accelerate National Digital Transformation

FPT Corporation, Vietnam’s leading technology conglomerate and the Ministry of National Development Planning of the Republic of Indonesia (Bappenas) have signed a landmark Memorandum of Understanding (MoU) to advance Indonesia’s digital transformation, foster innovation, and develop future-ready digital talent in support of the nation’s long-term vision, Golden Indonesia 2045. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250612146...

06/10/2025 13:05
Amsterdam-based Tebi Announces €30 Million Investment Led by Alphabet growth fund CapitalG to transform hospitality operations

Tebi, the Amsterdam-based startup developing an all-in-one financial operating system for hospitality, today announced a €30 million investment led by Alphabet independent growth fund CapitalG, with participation from existing investor Index Ventures. This follows Tebi’s €20 million Series A announced just six months ago and brings the company’s total funding to €56 million. The financing reflects the company’s momentum across product innovation, hiring and expansion into new markets. The inv...

06/10/2025 13:07
Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ® Mixer

Medisca and FlackTek have reached a settlement to resolve their patent dispute relating to the Medisca MAZ® mixer and related mixing technologies set forth in Medisca U.S. patent numbers 10,420,705, 10,765,600, 11,090,224, 11,096,864, 10,231,903, and 10,993,876. The confidential settlement resolves the pending litigation. “This settlement validates the investment Medisca has made over the past decade in the MAZ innovation and technology,” said Sanjay Goorachurn, CEO of Medisca Pharmaceutique ...